Table 1.
Therapeutic index.
Drug | HIF1α degradation a) (IC50, µM) | Normal cell cytotoxicity b) (IC50, µM) | Therapeutic index (B/A) |
---|---|---|---|
MitoQ | 0.077 ± 0.016 | 22.47 ± 0.46 | 295.81 |
SB‐U014 | 0.040 ± 0.091 | 27.47 ± 0.77 | 694.92 |
SB‐U015 | 0.041 ± 0.083 | 31.78 ± 0.76 | 773.05 |
IC50 values of HIF1α protein degradation in MIO‐M1 cells upon TRAP1 inhibitor treatment were analyzed as in Figure 7A,B (n = 4);
IC50 values of the cytotoxic activities of the drugs in primary Müller cells were calculated as in Figure S18A, Supporting information (n = 4). The therapeutic index[ 42 ] was determined as (IC50 for normal cell cytotoxicity)/(IC50 for HIF1α degradation). Data information: Data are expressed as mean ± SEM.